Menu
 
Research menu
Jump to menu

Publications:  Dr Alessandra Nerviani

Rivellese F, Humby F, Bugatti S, Fossati-Jimack L, Rizvi H, Lucchesi D, Lliso-Ribera G, Nerviani A et al.(2020). B cell synovitis and clinical phenotypes in rheumatoid arthritis: relationship to disease stages and drug exposure. Arthritis and Rheumatology
10.1002/art.41184
https://qmro.qmul.ac.uk/xmlui/handle/123456789/63258
Bellan M, Andreoli L, Nerviani A, Piantoni S, Avanzi GC, Soddu D, Hayden E, Pirisi M et al.(2020). Is cholecalciferol a potential disease-modifying anti-rheumatic drug for the management of rheumatoid arthritis?. Clin Exp Rheumatol vol. 38, (2) 343-349.
Bellan M, Patrucco F, Barone-Adesi F, Gavelli F, Castello LM, Nerviani A, Andreoli L, Cavagna L et al.(2020). Targeting CD20 in the treatment of interstitial lung diseases related to connective tissue diseases: A systematic review. Autoimmun Rev vol. 19, (2)
10.1016/j.autrev.2019.102453
Pagani S, Bellan M, Mauro D, Castello LM, Avanzi GC, Lewis MJ, Sainaghi PP, Pitzalis C et al.(2020). New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis. Disease Markers vol. 2020, Article 1614627,
10.1155/2020/1614627
https://qmro.qmul.ac.uk/xmlui/handle/123456789/62984
Lliso-Ribera G, Humby F, Lewis M, Nerviani A, Mauro D, Rivellese F, Kelly S, Hands R et al.(2019). Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: Results from the pathobiology of early arthritis cohort (PEAC). Annals of the Rheumatic Diseases vol. 78, (12) 1642-1652.
10.1136/annrheumdis-2019-215751
https://qmro.qmul.ac.uk/xmlui/handle/123456789/63523
Rodríguez-Ubreva J, De La Calle-Fabregat C, Li T, Ciudad L, Ballestar ML, Català-Moll F, Morante-Palacios O, Garcia-Gomez A et al.(2019). Inflammatory cytokines shape a changing DNA methylome in monocytes mirroring disease activity in rheumatoid arthritis. Annals of the Rheumatic Diseases vol. 78, (11) 1505-1516.
10.1136/annrheumdis-2019-215355
Rivellese F, Lliso-Ribera G, Nerviani A, Humby F, Pitzalis C (2019). Persistence of B Cell-rich Synovitis Following Conventional Synthetic Disease Modifying Anti-Rheumatic Drug Treatment in Early Rheumatoid Arthritis Is Associated with Radiographic Progression Independently of Clinical Response. ARTHRITIS & RHEUMATOLOGY. vol. 71,
Mauro D, Macaluso F, Nerviani A, Boutet M-A, Rizzo A, Alessandro R, Guggino G, Pitzalis C et al. (2019). The Deubiquitinase TRABID Is a Potential Therapeutic Target in Spondyloarthritis. ARTHRITIS & RHEUMATOLOGY. vol. 71,
Mattiola I, Tomay F, De Pizzol M, Silva-Gomes R, Savino B, Gulic T, Doni A, Lonardi S et al. (2019). The macrophage tetraspan MS4A4A enhances Dectin-1-dependent NK cell-mediated resistance to metastasis. EUROPEAN JOURNAL OF IMMUNOLOGY. vol. 49, 1517-1518.
Boutet M-A, Nerviani A, Lliso-Ribera G, Lucchesi D, Prediletto E, Ghirardi GM, Goldmann K, Lewis M et al.(2019). Interleukin-36 family dysregulation drives joint inflammation and therapy response in psoriatic arthritis. Rheumatology
10.1093/rheumatology/kez358
https://qmro.qmul.ac.uk/xmlui/handle/123456789/62220
Mattiola I, Tomay F, De Pizzol M, Silva-Gomes R, Savino B, Gulic T, Doni A, Lonardi S et al. (2019). The macrophage tetraspan MS4A4A enhances Dectin-1-dependent NK cell-mediated resistance to metastasis. EUROPEAN JOURNAL OF IMMUNOLOGY. vol. 49, 17-18.
Mattiola I, Tomay F, De Pizzol M, Silva-Gomes R, Savino B, Gulic T, Doni A, Lonardi S et al.(2019). The macrophage tetraspan MS4A4A enhances dectin-1-dependent NK cell–mediated resistance to metastasis. Nature Immunology vol. 20, (8) 1012-1022.
10.1038/s41590-019-0417-y
https://qmro.qmul.ac.uk/xmlui/handle/123456789/58603
El Shikh MEM, El Sayed R, Nerviani A, Goldmann K, John CR, Hands R, Fossati-Jimack L, Lewis MJ et al.(2019). Extracellular traps and PAD4 released by macrophages induce citrullination and auto-antibody production in autoimmune arthritis. Journal of Autoimmunity
10.1016/j.jaut.2019.06.008
https://qmro.qmul.ac.uk/xmlui/handle/123456789/58983
Rivellese F, Humby F, Bugatti S, Fossati-Jimack L, Rizvi H, Lucchesi D, Ribera GL, Nerviani A et al. (2019). B CELL SYNOVITIS AND CLINICAL PHENOTYPES IN RHEUMATOID ARTHRITIS AT DIFFERENT DISEASE STAGES. ANNALS OF THE RHEUMATIC DISEASES. vol. 78, 296-297.
10.1136/annrheumdis-2019-eular.1284
Ribera GL, Humby F, Nerviani A, Lewis M, Kelly S, Bombardieri M, Goldmann K, Hands R et al. (2019). BASELINE CELLULAR AND MOLECULAR CHARACTERISTICS OF SYNOVIAL TISSUE AND RELATION WITH TNFI RESPONSE. RESULTS FROM THE PATHOBIOLOGY OF THE EARLY ARTHRITIS COHORT (PEAC). ANNALS OF THE RHEUMATIC DISEASES. vol. 78, 134-134.
10.1136/annrheumdis-2019-eular.2617
Nerviani A, Humby F, Ribera GL, Rivellese F, Kelly S, Hands R, Pitzalis C (2019). DEFINING A LEARNING CURVE FOR CLINICIANS PERFORMING ULTRASOUND-GUIDED DEFINING A LEARNING CURVE FOR CLINICIANS PERFORMING ULTRASOUND-GUIDED NEEDLE SYNOVIAL BIOPSIES: A RETROSPECTIVE ANALYSIS OF THE EXPERIENCE AT THE EXPERIMENTAL MEDICINE AND RHEUMATOLOGY, QUEEN MARY UNIVERSITY OF LONDON. ANNALS OF THE RHEUMATIC DISEASES. vol. 78, 317-317.
10.1136/annrheumdis-2019-eular.7302
Nerviani A, Ribera GL, Boutet MA, Goldmann K, Kelly S, Bombardieri M, Lewis M, Humby F et al. (2019). HISTOLOGICAL AND MOLECULAR PORTRAIT OF THE SYNOVIAL TISSUE IN EARLY TREATMENT-NAIVE PSORIATIC ARTHRITIS IN COMPARISON WITH RHEUMATOID ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES. vol. 78, 130-131.
10.1136/annrheumdis-2019-eular.3634
Boutet M-A, Nerviani A, Pitzalis C(2019). IL-36, IL-37, and IL-38 Cytokines in Skin and Joint Inflammation: A Comprehensive Review of Their Therapeutic Potential. Int J Mol Sci vol. 20, (6)
10.3390/ijms20061257
https://qmro.qmul.ac.uk/xmlui/handle/123456789/58681
Boutet M-A, Nerviani A, Lliso-Ribera G, Goldmann K, Lewis M, Pitzalis C (2019). IL-36 AXIS IS AN EMERGING THERAPEUTIC TARGET IN PSORIATIC ARTHRITIS SYNOVIAL TISSUE. ANNALS OF THE RHEUMATIC DISEASES. vol. 78, A56-A56.
10.1136/annrheumdis-2018-EWRR2019.113
Nerviani A, Mauro D, Gilio M, Grembiale RD, Lewis MJ(2018). To supplement or not to supplement? The rationale of vitamin D supplementation in systemic lupus erythematosus. Open Rheumatology Journal vol. 12, 226-247.
10.2174/1874312901812010226
https://qmro.qmul.ac.uk/xmlui/handle/123456789/57680
Rivellese F, Mauro D, Nerviani A, Pagani S, Fossati-Jimack L, Messemaker T, Kurreeman FAS, Toes REM et al.(2018). Mast cells in early rheumatoid arthritis associate with disease severity and support B cell autoantibody production. Annals of the Rheumatic Diseases vol. 77, (12) 1773-1781.
10.1136/annrheumdis-2018-213418
https://qmro.qmul.ac.uk/xmlui/handle/123456789/44263
Cecchinato V, D'Agostino G, Raeli L, Nerviani A, Schiraldi M, Danelon G, Manzo A, Thelen M et al.(2018). Redox-Mediated Mechanisms Fuel Monocyte Responses to CXCL12/HMGB1 in Active Rheumatoid Arthritis. Frontiers in Immunology vol. 9, 2118-2118.
10.3389/fimmu.2018.02118
Nerviani A, Humby F, Ribera GL, Tan WS, Boutet MA, Goldmann K, Bene F, Hands R et al. (2018). Comparative Histologic and Molecular Analysis of Synovial Tissue in Early Treatment-Naive Psoriatic and Rheumatoid Arthritis. ARTHRITIS & RHEUMATOLOGY. vol. 70,
Mauro D, Nerviani A(2018). Endothelial Dysfunction in Systemic Lupus Erythematosus: Pathogenesis, Assessment and Therapeutic Opportunities. Rev Recent Clin Trials vol. 13, (3) 192-198.
10.2174/1574887113666180314091831
https://qmro.qmul.ac.uk/xmlui/handle/123456789/42643
Nerviani A, Pitzalis C(2018). Role of chemokines in ectopic lymphoid structures formation in autoimmunity and cancer. J Leukoc Biol vol. 104, (2) 333-341.
10.1002/JLB.3MR0218-062R
https://qmro.qmul.ac.uk/xmlui/handle/123456789/42083
Boutet M-A, Nerviani A, Lliso-Ribera G, Goldmann K, Lewis M, Pitzalis C (2018). IL-36 AXIS IS AN EMERGING THERAPEUTIC TARGET IN PSORIATIC ARTHRITIS SYNOVIAL TISSUE. ANNALS OF THE RHEUMATIC DISEASES. vol. 77, 885-885.
10.1136/annrheumdis-2018-eular.3485
Purkayastha N, Tan WS, Mahto A, Lewis M, Lliso G, Nerviani A, Rocher V, Humby F et al. (2018). IMAGING CHARACTERISATION OF REMISSION IN RHEUMATOID ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES. vol. 77, 282-283.
10.1136/annrheumdis-2018-eular.1264
Nerviani A, Mauro D, Pagani S, Lliso-Ribera G, Rivellese F, Lewis M, Bombardieri M, Humby F et al. (2018). RESTRICTED AXL SYNOVIAL EXPRESSION AND INCREASED CLEAVAGE OF AXL ECTODOMAIN CORRELATE WITH HIGHLY INFLAMED SYNOVITIS AND MORE SEVERE RHEUMATOID ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES. vol. 77, 255-255.
10.1136/annrheumdis-2018-eular.6988
Lliso-Ribera G, Humby F, Nerviani A, Boutet MA, Kelly S, Bombardieri M, Lewis M, Hands R et al. (2018). SYNOVIAL CELL INFILTRATION IN ACPA-VE PATIENTS DISPLAYS SIMILAR SIGNATURES TO OTHER SERONEGATIVE INFLAMMATORY ARTHRITIS. RESULTS FROM THE PATHOBIOLOGY OF EARLY ARTHRITIS COHORT (PEAC). ANNALS OF THE RHEUMATIC DISEASES. vol. 77, 71-72.
10.1136/annrheumdis-2018-eular.3489
Rivellese F, Nerviani A, Mauro D, Pagani S, Humby F, Pitzalis C (2018). SYNOVIAL MAST CELLS AND RESPONSES TO SYNTHETIC AND BIOLOGIC DMARDS IN EARLY AND ESTABLISHED RHEUMATOID ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES. vol. 77, 900-901.
10.1136/annrheumdis-2018-eular.6839
Ribera GL, Humby F, Kelly S, Lewis M, Bombardieri M, Nerviani A, Hands R, Bene F et al. (2018). A LYMPHOID PATHOTYPE AT BASELINE, IN EARLY INFLAMMATORY ARTHRITIS, SIGNIFICANTLY ASSOCIATES WITH REQUIREMENT FOR BIOLOGIC THERAPY AT 12 MONTHS FOLLOW UP: RESULTS FROM THE PATHOBIOLOGY OF EARLY ARTHRITIS COHORT. RHEUMATOLOGY. vol. 57,
Ribera GL, Humby F, Kelly S, Lewis M, Bornbardieri M, Nerviani A, Hands R, Bene F et al. (2018). THE CLINICAL PHENOTYPE OF INFLAMMATORY ARTHRITIS CORRELATES WITH SYNOVIAL IMMUNE CELL INFILTRATION: RESULTS FROM THE PATHOBIOLOGY OF EARLY ARTHRITIS COHORT. RHEUMATOLOGY. vol. 57,
Boutet M-A, Nerviani A, Gallo Afflitto G, Pitzalis C(2018). Role of the IL-23/IL-17 Axis in Psoriasis and Psoriatic Arthritis: The Clinical Importance of Its Divergence in Skin and Joints. Int J Mol Sci vol. 19, (2)
10.3390/ijms19020530
https://qmro.qmul.ac.uk/xmlui/handle/123456789/57967
Rivellese F, Humby F, Pagani S, Nerviani A, Pitzalis C (2017). Persistence of Mast Cell-Rich Synovitis Is Associated with Lack of Response to Synthetic Disease Modifying Anti-Rheumatic Drugs in Patients with Early Rheumatoid Arthritis. ARTHRITIS & RHEUMATOLOGY. vol. 69,
Mauro D, Tsang V, Clayton-Lucey IA, Pagani S, Alam F, Pontarini E, Nerviani A, Pakozdi A et al. (2017). Regulation of TLR7 Signalling By UBE2L3 Dependent Linear Ubiquitination Explains Dimethyl Fumarate Suppression of Autoreactive B Cell Development in SLE. ARTHRITIS & RHEUMATOLOGY. vol. 69,
Nerviani A, Pagani S, Mauro D, Humby F, Kelly S, Rivellese F, Ribera GL, Lewis MJ et al. (2017). Tyrosine Kinase Receptor Axl Is Down Regulated in Highly Inflamed Rheumatoid Synovium and Negatively Correlates with Markers of Disease Activity. ARTHRITIS & RHEUMATOLOGY. vol. 69,
NERVIANI A (2017). TAM receptors in rheumatoid arthritis: focus on synovial expression, relationship with synovial histopathology and association with clinical evolution and response to treatment. Supervisors: PITZALIS, C, BOMBARDIERI, M,
Lliso-Ribera G, Humby F, Kelly S, Bombardieri M, Lewis M, Hands R, Rocher V, Bene F et al. (2017). IN EARLY INFLAMMATORY ARTHRITIS A LYMPHOID PATHOTYPE SIGNFICANTLY ASSOCIATES WITH REQUIREMENT FOR BIOLOGIC THERAPY AT 12 MONTHS FOLLOW UP: RESULTS FROM THE PATHOBIOLOGY OF EARLY ARTHRITIS COHORT (PEAC). ANNALS OF THE RHEUMATIC DISEASES. vol. 76, 238-238.
10.1136/annrheumdis-2017-eular.6042
Rivellese F, Nerviani A, Rossi FW, Marone G, Matucci-Cerinic M, de Paulis A, Pitzalis C(2017). Mast cells in rheumatoid arthritis: friends or foes?. Autoimmunity Reviews vol. 16, (6) 557-563.
10.1016/j.autrev.2017.04.001
https://qmro.qmul.ac.uk/xmlui/handle/123456789/50024
Rivellese F, Humby F, Nerviani A, Pagani S, Mauro D, de Paulis A, Marone G, Pitzalis C (2017). SYNOVIAL MAST CELLS IDENTIFY PATIENTS WITH A SEVERE PHENOTYPE IN A COHORT OF DMARD NAIVE PATIENTS WITH EARLY RHEUMATOID ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES. vol. 76, 490-491.
10.1136/annrheumdis-2017-eular.6393
Lliso-Ribera G, Humby F, Kelly S, Bombardieri M, Lewis M, Hands R, Rocher V, Bene F et al. (2017). SYNOVIAL PATHOBIOLOGY CORRELATES WITH DIAGNOSTIC SUBGROUPS IN EARLY INFLAMMATORY ARTHRITIS: RESULTS FROM THE PATHOBIOLOGY OF EARLY ARTHRITIS COHORT (PEAC). ANNALS OF THE RHEUMATIC DISEASES. vol. 76, 511-511.
10.1136/annrheumdis-2017-eular.2927
Corsiero E, Nerviani A, Bombardieri M, Pitzalis C(2016). Ectopic Lymphoid Structures: Powerhouse of Autoimmunity. Front Immunol vol. 7, Article 00430, 430-430.
10.3389/fimmu.2016.00430
https://qmro.qmul.ac.uk/xmlui/handle/123456789/31464
Jones GW, Bombardieri M, Greenhill CJ, McLeod L, Nerviani A, Rocher-Ros V, Cardus A, Williams AS et al. (2016). Interleukin-27 inhibits synovial lymphoid neogenesis in inflammatory arthritis. EUROPEAN JOURNAL OF IMMUNOLOGY. vol. 46, 1024-1024.
Nerviani A, DiCicco M, Humby F, Kelly S, Zou L, Lewis M, Hands R, Rocher V et al. (2016). A BASELINE PREDICTION MODEL FOR RESPONSE TO CERTOLIZUMAB-PEGOL: ROLE OF SYNOVIAL HISTOPATHOLOGY. ANNALS OF THE RHEUMATIC DISEASES. vol. 75, 485-486.
10.1136/annrheumdis-2016-eular.4218
Nerviani A, Tan WS, Mahto A, Di Cicco M, Lazarou I, Ng N, Purkayastha N, Bellan M et al. (2016). HISTOPATHOLOGY OF TREATMENT-NAIVE PSORIATIC SYNOVITIS: A COMPARISON WITH EARLY RHEUMATOID ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES. vol. 75, 595-596.
10.1136/annrheumdis-2016-eular.5321
Rivellese F, Humby F, Kelly S, Nerviani A, Mauro D, Rocher-Ros V, El Shikh ME, de Paulis A et al. (2016). SYNOVIAL MAST CELLS CORRELATE WITH LOCAL AND SYSTEMIC INFLAMMATION AND ARE FUNCTIONALLY ASSOCIATED WITH ECTOPIC LYMPHOID STRUCTURES IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS. Presented at: EULAR 2016,
https://qmro.qmul.ac.uk/xmlui/handle/123456789/51563
Nerviani A, DiCicco M, Kelly S, Humby F, Hands R, Zou L, Lewis M, Rocher V et al. (2016). FIBROID SYNOVIAL PATHOTYPE AND TYROSINE KINASE AXL CORRELATE WITH POOR CLINICAL RESPONSE TO CERTOLIZUMAB PEGOL IN RHEUMATOID ARTHRITIS PATIENTS. Rheumatology. Conference: Rheumatology 2016 from: 26/09/2016 to: 28/04/2016, vol. 55, 61-61.
10.1093/rheumatology/kew121.004
Sorice M, Iannuccelli C, Manganelli V, Capozzi A, Alessandri C, Lococo E, Garofalo T, Di Franco M et al.(2016). Autophagy generates citrullinated peptides in human synoviocytes: a possible trigger for anti-citrullinated peptide antibodies. Rheumatologykew178-kew178.
10.1093/rheumatology/kew178
Lepse N, Nerviani A, Pitzalis C, Bombardieri M (2016). T FOLLICULAR HELPER-LIKE CELLS IN THE RHEUMATOID ARTHRITIS SYNOVIUM ARE SELECTIVELY ASSOCIATED WITH INTERLEUKIN-21 PRODUCTION AND ECTOPIC LYMPHOID STRUCTURES. RHEUMATOLOGY. vol. 55, 89-89.
Lepse N, Nerviani A, Pitzalis C, Bombardieri M (2016). TFH-LIKE CELLS IN THE RA SYNOVIUM ARE SELECTIVELY ASSOCIATED WITH IL-21 PRODUCTION AND ECTOPIC LYMPHOID STRUCTURES. ANNALS OF THE RHEUMATIC DISEASES. vol. 75, A27-A27.
10.1136/annrheumdis-2016-209124.65
Headland SE, Jones HR, Norling LV, Kim A, Souza PR, Corsiero E, Gil CD, Nerviani A et al.(2015). Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis. Science Translational Medicine vol. 7, (315)
10.1126/scitranslmed.aac5608
Jones GW, Bombardieri M, Greenhill CJ, McLeod L, Nerviani A, Rocher-Ros V, Cardus A, Williams AS et al.(2015). Interleukin-27 inhibits ectopic lymphoid-like structure development in early inflammatory arthritis. Journal of Experimental Medicine vol. 212, (11) 1793-1802.
10.1084/jem.20132307
Nerviani A, Humby F, Kelly S, Bombardieri M, Pitzalis C (2015). A FUNCTIONAL INHIBITORY ROLE FOR THE GAS6/MERTK AXIS IN MODULATING SYNOVIAL INFLAMMATION IN RHEUMATOID ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES. vol. 74, 204-204.
10.1136/annrheumdis-2015-eular.5727
Decourcey J, Nerviani A, Melgar S, Bulfone-Paus S, Loscher CE, Bombardieri M, Pitzalis C (2015). SNARE REGULATION OF TH17 CELLS AND ECTOPIC LYMPHOID STRUCTURE (ELS) FORMATION IN RHEUMATOID ARTHRITIS. ANNALS OF THE RHEUMATIC DISEASES. vol. 74, 112-113.
10.1136/annrheumdis-2015-eular.1721
Tan WS, Bellan M, Nerviani A, Di Cicco M, Mahto A, Lazarou I, Hands R, Humby F et al. (2015). SYNOVIAL IMMUNOPATHOLOGY DEFINES CLINICAL RESPONSIVENESS TO DMARD THERAPY IN EARLY PSORIATIC ARTHRITIS: A PRE- AND POST-TREATMENT MECHANISTIC STUDY USING A MINIMALLY INVASIVE ULTRASOUND-GUIDED SYNOVIAL BIOPSY PROCEDURE. ANNALS OF THE RHEUMATIC DISEASES. vol. 74, 149-150.
10.1136/annrheumdis-2015-eular.3182
Astorri E, Nerviani A, Bombardieri M, Pitzalis C(2015). Towards a stratified targeted approach with biologic treatments in rheumatoid arthritis: Role of synovial pathobiology. Current Pharmaceutical Design vol. 21, (17) 2216-2224.
10.2174/1381612821666150310145758
Di Cicco M, Humby F, Kelly S, Ng N, Mahto A, Lazarou I, Hands RE, Rocher V et al. (2015). SYNOVIAL PATHOTYPE PREDICTS RESPONSE TO TNF-ALPHA INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS. RHEUMATOLOGY. vol. 54, 6-6.
Di Cicco M, Kelly S, Humby F, Ng N, Nerviani A, Rocher V, Hands R, Bombardieri M et al. (2014). SYNOVIAL LYMPHOCYTIC AGGREGATES PREDICT CLINICAL RESPONSE TO CERTOLIZUMAB PEGOL IN RHEUMATOID ARTHRITIS (CLINICAL AND PATHOLOGICAL RESPONSE TO CERTOLIZUMAB-PEGOL (CLIP-CERT) STUDY). ANNALS OF THE RHEUMATIC DISEASES. vol. 73, 606-607.
10.1136/annrheumdis-2014-eular.5564
Di Cicco M, Kelly S, Humby F, Ng N, Hands RE, Rocher V, Nerviani A, Zou L et al. (2014). SYNOVIAL ECTOPIC LYMPHONEOGENESIS PREDICTS PRIMARY CLINICAL RESPONSE TO CERTOLIZUMAB PEGOL IN PATIENTS WITH RHEUMATOID ARTHRITIS. RHEUMATOLOGY. vol. 53, 95-95.
Di Cicco M, Kelly S, Humby F, Ng N, Dadoun S, Hands R, Rocher V, Nerviani A et al. (2013). Synovial Ectopic Lymphoneogenesis Predicts Clinical Response To Certolizumab Pegol In Patients With Rheumatoid Arthritis. ARTHRITIS AND RHEUMATISM. vol. 65, S556-S556.
Sola D, Nerviani A, Molinari R, Rossi L, Cerutti C, Bellan M, Menegatti M, Pirisi M et al. (2013). SAFETY AND EFFICACY OF RHEUMATOID ARTHRITIS TREATMENT WITH MODIFIED-RELEASE PREDNISONE (MR-PDN), EXPERIENCE IN "REAL LIFE". ANNALS OF THE RHEUMATIC DISEASES. vol. 72, 893-893.
Sainaghi PP, Bellan M, Nerviani A, Sola D, Molinari R, Cerutti C, Pirisi M(2013). Superiority of a high loading dose of cholecalciferol to correct hypovitaminosis D in patients with inflammatory/autoimmune rheumatic diseases. Journal of Rheumatology vol. 40, (2) 166-172.
10.3899/jrheum.120536
Sainaghi PP, Bellan M, Carda S, Cerutti C, Sola D, Nerviani A, Molinari R, Cisari C et al.(2012). Hypovitaminosis D and response to cholecalciferol supplementation in patients with autoimmune and non-autoimmune rheumatic diseases. Rheumatology International vol. 32, (11) 3365-3372.
10.1007/s00296-011-2170-x
Return to top